{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03710889","recordId":"NCT03710889","peptideSlug":"abaloparatide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03710889-abaloparatide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03710889.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03710889.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2018-10-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2018-10-17","publishedAt":"2026-08-23","recordId":"NCT03710889","recordSha256":"82d011c8c609f0aa7dd6ff90d61e183440179a2913e9699c98a3e1a84fa44e25","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03710889?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2020-03-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2020-03-10","publishedAt":"2026-08-23","recordId":"NCT03710889","recordSha256":"00521c35825749cb427d898f65485d0ed571c9701e87922d1a58eef8844619b4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03710889?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2020-09-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2020-09-21","publishedAt":"2026-08-23","recordId":"NCT03710889","recordSha256":"b5b398e72bca8da5e422ffb4590b70063276a1e7ad18da4ec14d6724a4a43792","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03710889?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Document Section","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2021-10-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"abaloparatide","submittedDate":"2021-10-12","publishedAt":"2026-08-23","recordId":"NCT03710889","recordSha256":"a32c42850d285bd2a148c1b1519d93f889dd718b38e566028141830dc0603c8d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03710889?a=5&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"f532603fb04d3a7a72e3be02356819df400f8c175740e2949ee4a0f16d8b0eee"}}